Print Page  Close Window    

Investor Relations Home

Corporate Profile

La Jolla Pharmaceutical Company is a publicly traded biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases.

Featured Documents

04/11/17Corporate Presentation

Share Price

Stock chart for: LJPC.OQ.  Currently trading at $29.02 with a 52 week high of $39.26 and a 52 week low of $14.65.
Price$29.02
Change (%) Stock is Down 0.93 (3.11%)
Volume100,114
Data as of 05/26/17 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.


Upcoming Events




There are currently no events scheduled.

Recent News


Results of ATHOS-3 Phase 3 Study of LJPC-501 Published in The New England Journal of Medicine

05/21/17

SAN DIEGO--(BUSINESS WIRE)--May 21, 2017-- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (La Jolla) today announced that results of the ATHOS-3 (Angiotensin II for the Treatment of High-Output Shock) Phase 3 study of LJPC

Read More

La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress

04/27/17

SAN DIEGO--(BUSINESS WIRE)--Apr. 27, 2017-- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patien

Read More

La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock

03/23/17

SAN DIEGO--(BUSINESS WIRE)--Mar. 23, 2017-- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (“La Jolla” or the “Company”), a leader in the development of innovative therapies intended to significantly improve outcomes in patients

Read More